Chronic lymphocytic leukaemia trials in Romania

1 of 10 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia

  Where

  Bucharest

  Age

  18 years and over

  People

  60

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07602088